← Open Payments lookup

DANA HONG: Open Payments

NPI 1073017604 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,325 in 180 payments from 21 companies in 2025. Trend: 2023 $885 · 2024 $4,525 · 2025 $4,325

Food & beverage: $4,325
CompanyPaymentsAmount
ABBVIE INC.46$911
Janssen Biotech, Inc.18$715
Takeda Pharmaceuticals U.S.A., Inc.23$602
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$257
Celltrion USA Inc.8$238
Regeneron Healthcare Solutions, Inc.7$212
Madrigal Pharmaceuticals11$189
GENZYME CORPORATION5$148
Phathom Pharmaceuticals, Inc.3$146
QOL Medical, LLC5$126

Products named: TREMFYA, DUPIXENT, RINVOQ, ENTYVIO, XIFAXAN, ARALAST, REZDIFFRA, SKYRIZI.

Industry payments across TX — which companies pay providers there.